Author:
Lee Yun-Sang,Jeong Jae Min
Publisher
Springer Berlin Heidelberg
Reference89 articles.
1. Anderson CJ, Dehdashti F, Cutler PD, Schwarz SW, Laforest R, Bass LA et al (2001) Cu-64-TETA-Octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 42(2):213–221
2. Areberg J, Norrgren K, Mattsson S (1999) Absorbed doses to patients from 191Pt-, 193mPt- and 195mPt-cisplatin. Appl Radiat Isot 51(5):581–586
3. Bodei L, Handkiewicz-Junak D, Grana C, Mazzetta C, Rocca P, Bartolomei M et al (2004) Receptor radionuclide therapy with Y-90-DOTATOC in patients with medullary thyroid carcinomas. Cancer Biother Radiopharm 19(1):65–71
4. Boswell CA, Sun XK, Niu WJ, Weisman GR, Wong EH, Rheingold AL et al (2004) Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem 47(6):1465–1474
5. Brechbiel MW (2008) Bifunctional chelates for metal nuclides. Q J Nucl Med Mol Imaging 52(2):166–173. Epub 2007/11/29
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献